| pubmed-article:17963047 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17963047 | lifeskim:mentions | umls-concept:C0017398 | lld:lifeskim |
| pubmed-article:17963047 | lifeskim:mentions | umls-concept:C0039082 | lld:lifeskim |
| pubmed-article:17963047 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17963047 | pubmed:dateCreated | 2007-11-9 | lld:pubmed |
| pubmed-article:17963047 | pubmed:abstractText | Sjögren's syndrome (SS) is a complex polygenic autoimmune disorder. A few major genetic effects have been identified. Historically, HLA and non-HLA genetic associations have been reported. Recently, the HLA region continued to reveal association findings. A new susceptibility region has been suggested by a study of a D6S349 microsatellite marker. Among non-HLA studies, recent association of immunoglobulin kappa chain allotype KM1 with anti-La autoantibodies in primary Sjögren's syndrome confirms findings in a study from two decades ago. Meanwhile, mouse models have been employed to study the genetic contribution to salivary lymphadenitis or dry eyes and mouth. Gene transfer exploration in mouse models shows promise. The authors review the HLA and non-HLA association studies and the mouse model work that has been reported. Newly developed genomic capacity will provide, in the future, a much closer approximation of the true picture of the genetic architecture of Sjögren's syndrome. | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17963047 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17963047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17963047 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17963047 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17963047 | pubmed:issn | 1080-0549 | lld:pubmed |
| pubmed-article:17963047 | pubmed:author | pubmed-author:ScofieldR... | lld:pubmed |
| pubmed-article:17963047 | pubmed:author | pubmed-author:HarleyJohn... | lld:pubmed |
| pubmed-article:17963047 | pubmed:author | pubmed-author:NamjouBahramB | lld:pubmed |
| pubmed-article:17963047 | pubmed:author | pubmed-author:SawalhaAmr... | lld:pubmed |
| pubmed-article:17963047 | pubmed:author | pubmed-author:WilliamsPamel... | lld:pubmed |
| pubmed-article:17963047 | pubmed:author | pubmed-author:CobbBeth LBL | lld:pubmed |
| pubmed-article:17963047 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17963047 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:17963047 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17963047 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17963047 | pubmed:pagination | 201-9 | lld:pubmed |
| pubmed-article:17963047 | pubmed:meshHeading | pubmed-meshheading:17963047... | lld:pubmed |
| pubmed-article:17963047 | pubmed:meshHeading | pubmed-meshheading:17963047... | lld:pubmed |
| pubmed-article:17963047 | pubmed:meshHeading | pubmed-meshheading:17963047... | lld:pubmed |
| pubmed-article:17963047 | pubmed:meshHeading | pubmed-meshheading:17963047... | lld:pubmed |
| pubmed-article:17963047 | pubmed:meshHeading | pubmed-meshheading:17963047... | lld:pubmed |
| pubmed-article:17963047 | pubmed:meshHeading | pubmed-meshheading:17963047... | lld:pubmed |
| pubmed-article:17963047 | pubmed:meshHeading | pubmed-meshheading:17963047... | lld:pubmed |
| pubmed-article:17963047 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17963047 | pubmed:articleTitle | Horizons in Sjögren's syndrome genetics. | lld:pubmed |
| pubmed-article:17963047 | pubmed:affiliation | Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City 73104, USA. | lld:pubmed |
| pubmed-article:17963047 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17963047 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:17963047 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:17963047 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17963047 | lld:pubmed |
